Loading...
Toward Healthy Drug Policy in the United States — The Case of Safehouse
Anderson, Evan Davis, Corey S. Beletsky, Leo
Anderson, Evan
Davis, Corey S.
Beletsky, Leo
Citations
Altmetric:
Genre
Journal article
Date
2020-02-02
Advisor
Committee member
Department
Law
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://www.nejm.org/doi/10.1056/NEJMp1913448
Abstract
Description
A new Perspective article in the New England Journal of Medicine examines a recent decision by a Philadelphia judge to reject the argument that an overdose prevention site, called Safehouse, would violate the Controlled Substances Act.The decision signals a move toward an approach to regulating drugs that minimizes both the harms of drugs and the harms caused by regulation itself – worthy goals all around, the authors write.
Citation
Scott Burris et al., Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382 New Eng. J. of Med. 4 (2020).
Citation to related work
Massachusetts Medical Society
From New England Journal of Medicine, Scott Burris, Evan Anderson, Corey S. Davis, Leo Beletsky, Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382, 4-5. Copyright © 2020 Massachusetts Medical Society. Reprinted with permission.
From New England Journal of Medicine, Scott Burris, Evan Anderson, Corey S. Davis, Leo Beletsky, Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382, 4-5. Copyright © 2020 Massachusetts Medical Society. Reprinted with permission.
Has part
New England Journal of Medicine, 382
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu